Ginkgo Bioworks was founded in 2008 by Jason Kelly, Reshma Shetty, Barry Canton, Austin Che, and Tom Knight. The company has not officially endorsed a plan to participate in an IPO.

Ginkgo specializes in leveraging biological processes in organisms to meet the needs of their clients in industries ranging from cosmetics to food goods. Their website claims the firm’s expertise is in cultured ingredients, strain improvement, and enzymes. The company has raised nearly $800 million in Venture Capital funding from investors including Reshape Holdings, T. Rowe Price, Innovation Camp, Illumia, Power Gate Ventures, Alrai Capital, OS Fund, Azure Capital Partners, Data Collective, Felicis Ventures, Vast Ventures, and Y Combinator. Per company press releases, Ginko last raised a Series E expansion in May 2020 bringing the round total to $360 million at a post-money valuation of nearly $5 billion.

Register for Details

For more details on financing and valuation for Ginkgo Bioworks, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Ginkgo Bioworks

Forge green plus iconForge green minus icon

What is Ginkgo Bioworks's IPO price?

Ginkgo Bioworks's IPO price is $1.18 as of 1/18/24.
Forge green plus iconForge green minus icon

What is Ginkgo Bioworks's funding to date?

Ginkgo Bioworks has raised $785.53MM to date.
Forge green plus iconForge green minus icon

When was Ginkgo Bioworks founded?

Ginkgo Bioworks was founded in 2008.

Who are Ginkgo Bioworks's major investors?

General Atlantic
Y Combinator
Viking Global Investors
T. Rowe Price
Bill Gates

Ginkgo Bioworks funding rounds and last known valuation

Date Funding Round Funding Raised Price per Share Last Known Valuation

Series E

$360MM raised $XXX.XX $XXX.XX

Series D

$275MM raised $XXX.XX $XXX.XX

Series C

$98.9MM raised $XXX.XX $XXX.XX

Series B

$51.63MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data
Updated on: Jul 17, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.